
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (CC BY).
ORIGINAL RESEARCH
Changes in plasma sphingolipid levels against the background of lipid-lowering therapy in patients with premature atherosclerosis
1 Central State Medical Academy of the Department of Presidential Affairs of the Russian Federation, Moscow, Russia
2 City Clinical Hospital № 51, Moscow, Russia
3 Institute of Biochemical Physics named after N. M. Emanuel, Moscow, Russia
4 Lomonosov Moscow State University, Moscow, Russia
Correspondence should be addressed: Larisa O. Minushkina
Marshala Timoshenko, 19, str. 1А, Moscow, 121359; ur.liam@anikhsunim
Funding: RFBR grant 19-04-00870А, Sphingolipidome Analysis of Cardiovascular Disease Markers.
Author contribution: Rogozhina AA — sampling, data acquisition; Alessenko AV — project management; Kurochkin IN — data analysis; Minushkina LO — data analysis, manuscript writing; Gutner UA, Shupik MA, Maloshitskaya OA — sample preparation, laboratory tests, data analysis; Lebedev AT, Zateyshchikov DA — study planning, data analysis, manuscript editing.
Compliance with ethical standards: the study was approved by the Ethics Committee of City Clinical Hospital № 51, Moscow (protocol № 02/19 dated February 7, 2019). Informed consent was submitted by all patients.